Home of the Parkinson's Improvement Programme


E-304 (aka. Palmitoyl ascorbate or ascorbyl palmitate) is to be used in a clinical trial as a remedy for the intractable pain of Trigeminal Neuralgia (TN). Up to now it has shown itself to be a 100% success even in cases where there has been TN pain for 30 years or more. There are no other remedies anywhere near so successful and most have unpleasant side-effects. In due course savings to the NHS will be in the order of tens of millions of £ per year.

1 Response to "News"

Andrew Carmichael

10th January 2023 at 8:00 pm

At last the initial trial is published
S. Khijmatgar, Z. Naik, A. Carmichael, S.M. Siddique, A. Bagewadi, A. Dey Chowdhury, M. Giacomello, M. Parrini, M. Rovati, F. Goker, C. Mortellaro, M. Del Fabbro, C. Chowdhury
Observational studies on the efficacy of carbamazepine and ascorbyl palmitate in managing trigeminal neuralgia

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 – N. 3 Suppl
Pages: 94-105
DOI: 10.26355/eurrev_202212_30799

Free to download

Further more extensive trials are in the process of funding

Leave a Reply

You must be logged in to post a comment.